Financial Gravity Asset Management, Inc. Immunity Bio, Inc. Transaction History
Financial Gravity Asset Management, Inc.
- $355 Billion
- Q1 2024
A detailed history of Financial Gravity Asset Management, Inc. transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Financial Gravity Asset Management, Inc. holds 17 shares of IBRX stock, worth $106. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17
Previous 2
750.0%
Holding current value
$106
Previous $11,000
754.55%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding IBRX
# of Institutions
191Shares Held
66.7MCall Options Held
2.27MPut Options Held
3.23M-
State Street Corp Boston, MA14.2MShares$89.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.5MShares$85 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.4MShares$65.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.48MShares$21.9 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V81.55MShares$9.73 Million0.01% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $2.51B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...